VVOS · Vivos Therapeutics, Inc. · Debt
$0.13
0.00 (-1.80%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.61M
Shares
20.12M
Volume · Oct 26
666.34K
Avg daily vol (3M)
14.76M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-06-30 | USD 56,000 | 10-Q filed 2026-08-14 |
| Current operating lease liabilities | 2026-06-30 | USD 790,000 | 10-Q filed 2026-08-14 |
| Long-term debt, including current maturities | 2026-06-30 | USD 582,000 | 10-Q filed 2026-08-14 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent finance lease liabilities | 2026-06-30 | USD 83,000 | 10-Q filed 2026-08-14 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 3,438,000 | 10-Q filed 2026-08-14 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.